The results showed a similar tendency (r = −0.82, P < 0.01), and patients with lymph node metastases also showed lower expression of RRAD along with higher expression levels of GLUT3 (Supplementary Fig. 7A, B). The gene discussed is SLC2A3; the disease is metastatic malignant neoplasm in the lymph nodes.